{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:47:11Z","timestamp":1786988831401,"version":"build-2736575974"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["ero.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EULAR Rheumatology Open"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.ero.2025.05.008","type":"journal-article","created":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T17:06:13Z","timestamp":1750957573000},"page":"81-88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effectiveness and safety of antiresorptive drugs in patients with systemic sclerosis\u2014a retrospective monocentric study"],"prefix":"10.1016","volume":"1","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-0378-3766","authenticated-orcid":false,"given":"Nils","family":"Schulz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2400-2840","authenticated-orcid":false,"given":"Tim","family":"Wilhelmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2629-1837","authenticated-orcid":false,"given":"Pascal","family":"van Wijnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8832-8112","authenticated-orcid":false,"given":"Ulf","family":"M\u00fcller-Ladner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7911-4235","authenticated-orcid":false,"given":"Philipp","family":"Klemm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10373","key":"10.1016\/j.ero.2025.05.008_bib0001","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0140-6736(22)01692-0","article-title":"Systemic sclerosis","volume":"401","author":"Volkmann","year":"2023","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.ero.2025.05.008_bib0002","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/1756-185X.12395","article-title":"The association between systemic sclerosis and bone mineral density- a meta-analysis of observational studies","volume":"17","author":"Wan","year":"2014","journal-title":"Int J Rheum Dis"},{"issue":"11","key":"10.1016\/j.ero.2025.05.008_bib0003","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.3899\/jrheum.130032","article-title":"Low bone density in systemic sclerosis. A systematic review","volume":"40","author":"Omair","year":"2013","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.ero.2025.05.008_bib0004","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s10067-022-06460-0","article-title":"High prevalence and risk factors for osteoporosis in 1839 patients with systemic sclerosis: a systematic review and meta-analysis","volume":"42","author":"Tu","year":"2023","journal-title":"Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.ero.2025.05.008_bib0005","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.rdc.2023.01.011","article-title":"Preventative care in scleroderma: what is the best approach to bone health and cancer screening?","volume":"49","author":"Calderon","year":"2023","journal-title":"Rheum Dis Clin North Am"},{"issue":"4","key":"10.1016\/j.ero.2025.05.008_bib0006","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s10067-019-04847-0","article-title":"A meta-analysis of fracture risk and bone mineral density in patients with systemic sclerosis","volume":"39","author":"Chen","year":"2020","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.ero.2025.05.008_bib0007","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s13018-019-1226-6","article-title":"Mortality after osteoporotic hip fracture: incidence, trends, and associated factors","volume":"14","author":"Guzon-Illescas","year":"2019","journal-title":"J Orthop Surg Res"},{"issue":"12","key":"10.1016\/j.ero.2025.05.008_bib0008","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1007\/s00198-010-1178-5","article-title":"Risk of subsequent fracture and mortality within 5 years after a non-vertebral fracture","volume":"21","author":"Huntjens","year":"2010","journal-title":"Osteoporos Int"},{"issue":"1","key":"10.1016\/j.ero.2025.05.008_bib0009","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s11657-020-00871-9","article-title":"SCOPE 2021: a new scorecard for osteoporosis in Europe","volume":"16","author":"Kanis","year":"2021","journal-title":"Arch Osteoporos"},{"issue":"4","key":"10.1016\/j.ero.2025.05.008_bib0010","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003524","article-title":"Excess mortality following a first and subsequent osteoporotic fracture: a Danish nationwide register-based cohort study on the mediating effects of comorbidities","volume":"9","author":"Christensen","year":"2023","journal-title":"RMD Open"},{"issue":"6","key":"10.1016\/j.ero.2025.05.008_bib0011","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/BOR.0000000000000899","article-title":"Gastrointestinal involvement in systemic sclerosis: pathogenesis, assessment and treatment","volume":"34","author":"Volkmann","year":"2022","journal-title":"Curr Opin Rheumatol"},{"issue":"2","key":"10.1016\/j.ero.2025.05.008_bib0012","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1055\/a-2438-9227","article-title":"Gastrointestinale Manifestationen bei systemischer Sklerose","volume":"45","author":"van Wijnen","year":"2025","journal-title":"Arthritis und Rheuma"},{"issue":"1","key":"10.1016\/j.ero.2025.05.008_bib0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10717544.2013.870259","article-title":"Bisphosphonates: therapeutics potential and recent advances in drug delivery","volume":"22","author":"Fazil","year":"2015","journal-title":"Drug Deliv"},{"issue":"4","key":"10.1016\/j.ero.2025.05.008_bib0014","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/joim.12873","article-title":"Treating osteoporosis to prevent fractures: current concepts and future developments","volume":"285","author":"Lorentzon","year":"2019","journal-title":"J Intern Med"},{"issue":"1","key":"10.1016\/j.ero.2025.05.008_bib0015","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.bone.2011.01.003","article-title":"Safety of bisphosphonates","volume":"49","author":"Pazianas","year":"2011","journal-title":"Bone"},{"issue":"11","key":"10.1016\/j.ero.2025.05.008_bib0016","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"9321","key":"10.1016\/j.ero.2025.05.008_bib0017","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/S0140-6736(02)08761-5","article-title":"Diagnosis of osteoporosis and assessment of fracture risk","volume":"359","author":"Kanis","year":"2002","journal-title":"Lancet"},{"key":"#cr-split#-10.1016\/j.ero.2025.05.008_bib0018.1","unstructured":"Thomasius F., K\u00fchlein T., Schober H.C., Siggelkow H., Schmidmaier R., Brabant T., et al. Prophylaxe, Diagnostik und Therapie der Osteoporose bei postmenopausalen Frauen und bei M\u00e4nnern ab dem 50. Lebensjahr: DVO-Leitlinie 2023. Version 2.2. Dachverband Osteologie (DVO)"},{"key":"#cr-split#-10.1016\/j.ero.2025.05.008_bib0018.2","unstructured":"2023 [cited 2025 Jun 20]. Available from: https:\/\/leitlinien.dv-osteologie.org\/wp-content\/uploads\/2025\/05\/05-2025_DVO-Leitlinie-zur-Diagnostik-und-Therapie-der-Osteoporose-Version-2.2.-2023-25.pdf."},{"issue":"1","key":"10.1016\/j.ero.2025.05.008_bib0019","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5301\/jsrd.5000231","article-title":"Standardization of the modified rodnan skin score for use in clinical trials of systemic sclerosis","volume":"2","author":"Khanna","year":"2017","journal-title":"J Scleroderma Relat Disord"},{"issue":"10","key":"10.1016\/j.ero.2025.05.008_bib0020","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20132014 update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.ero.2025.05.008_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2019.115157","article-title":"Denosumab failure associated with escape from suppression of bone resorption","volume":"131","author":"Jones","year":"2020","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.ero.2025.05.008_bib0022","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/jbmr.3641","article-title":"Change in bone density and reduction in fracture risk: a meta-regression of published trials","volume":"34","author":"Bouxsein","year":"2019","journal-title":"J Bone Miner Res"},{"issue":"8","key":"10.1016\/j.ero.2025.05.008_bib0023","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S2213-8587(20)30159-5","article-title":"Treatment-related changes in bone mineral density as a surrogate biomarker for fracture risk reduction: meta-regression analyses of individual patient data from multiple randomised controlled trials","volume":"8","author":"Black","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.ero.2025.05.008_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.apradiso.2022.110624","article-title":"Comparison of bone mineral density changes between male and female osteoporosis patients using dual energy X-ray absorptiometry scan","volume":"194","author":"Al-Bogami","year":"2023","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.ero.2025.05.008_bib0025","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.bone.2019.04.022","article-title":"Effects of long-term treatment of denosumab on bone mineral density: insights from an in-silico model of bone mineralization","volume":"125","author":"Mart\u00ednez-Reina","year":"2019","journal-title":"Bone"},{"issue":"10","key":"10.1016\/j.ero.2025.05.008_bib0026","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1210\/jc.2013-3795","article-title":"Time course of bone mineral density changes with denosumab compared with other drugs in postmenopausal osteoporosis: a dose-response-based meta-analysis","volume":"99","author":"Mandema","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.ero.2025.05.008_bib0027","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1359\/jbmr.2001.16.7.1212","article-title":"Discordance between changes in bone mineral density measured at different skeletal sites in perimenopausal women\u2013implications for assessment of bone loss and response to therapy: the Danish Osteoporosis Prevention Study","volume":"16","author":"Abrahamsen","year":"2001","journal-title":"J Bone Miner Res"},{"issue":"Suppl 3","key":"10.1016\/j.ero.2025.05.008_bib0028","first-page":"4","article-title":"The physiology of bone blood flow: a review","volume":"88","author":"McCarthy","year":"2006","journal-title":"J Bone Joint Surg Am"},{"issue":"9","key":"10.1016\/j.ero.2025.05.008_bib0029","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1093\/rheumatology\/key130","article-title":"Correlation between bone quality and microvascular damage in systemic sclerosis patients","volume":"57","author":"Ruaro","year":"2018","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.ero.2025.05.008_bib0030","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/s13075-019-2072-y","article-title":"Complex assessment of bone mineral density, fracture risk, vitamin D status, and bone metabolism in Hungarian systemic sclerosis patients","volume":"21","author":"Horv\u00e1th","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.ero.2025.05.008_bib0031","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.573976","article-title":"Oral treatment with bisphosphonates of osteoporosis does not increase the risk of severe gastrointestinal side effects: a meta-analysis of randomized controlled trials","volume":"11","author":"D\u00f6m\u00f6t\u00f6r","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"8","key":"10.1016\/j.ero.2025.05.008_bib0032","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1007\/s00296-024-05635-z","article-title":"Evaluation of oral health in 148 patients with systemic sclerosis-data from a prospective interdisciplinary monocentric cohort","volume":"44","author":"Pecher","year":"2024","journal-title":"Rheumatol Int"},{"issue":"2","key":"10.1016\/j.ero.2025.05.008_bib0033","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0291078","article-title":"Periodontal health status in systemic sclerosis patients: systematic review and meta-analysis","volume":"19","author":"Sredojevic","year":"2024","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.ero.2025.05.008_bib0034","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.joms.2013.02.016","article-title":"Oral health risk factors for bisphosphonate-associated jaw osteonecrosis","volume":"71","author":"Tsao","year":"2013","journal-title":"J Oral Maxillofac Surg"},{"issue":"4","key":"10.1016\/j.ero.2025.05.008_bib0035","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-027049","article-title":"Real-world persistence and adherence with oral bisphosphonates for osteoporosis: a systematic review","volume":"9","author":"Fatoye","year":"2019","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.ero.2025.05.008_bib0036","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/jbmr.3355","article-title":"Treatment-related changes in bone turnover and fracture risk reduction in clinical trials of anti-resorptive drugs: a meta-regression","volume":"33","author":"Bauer","year":"2018","journal-title":"J Bone Miner Res"},{"issue":"3","key":"10.1016\/j.ero.2025.05.008_bib0037","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00774-011-0326-0","article-title":"Osteoporosis Patient Treatment Satisfaction Questionnaire in postmenopausal women intermittently treated with oral bisphosphonates: the BRAVO study","volume":"30","author":"Oh","year":"2012","journal-title":"J Bone Miner Metab"},{"issue":"12","key":"10.1016\/j.ero.2025.05.008_bib0038","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1111\/1756-185X.13716","article-title":"Prevalence and incidence of systemic sclerosis: a systematic review and meta-analysis","volume":"22","author":"Zhong","year":"2019","journal-title":"Int J Rheum Dis"}],"container-title":["EULAR Rheumatology Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050708125000370?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050708125000370?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T15:47:15Z","timestamp":1763308035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3050708125000370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S3050708125000370"],"URL":"https:\/\/doi.org\/10.1016\/j.ero.2025.05.008","relation":{},"ISSN":["3050-7081"],"issn-type":[{"value":"3050-7081","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness and safety of antiresorptive drugs in patients with systemic sclerosis\u2014a retrospective monocentric study","name":"articletitle","label":"Article Title"},{"value":"EULAR Rheumatology Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ero.2025.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology (EULAR).","name":"copyright","label":"Copyright"}]}}